These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 23268924

  • 1. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes.
    Misaka S, Kawabe K, Onoue S, Werba JP, Giroli M, Tamaki S, Kan T, Kimura J, Watanabe H, Yamada S.
    Drug Metab Pharmacokinet; 2013; 28(3):244-9. PubMed ID: 23268924
    [Abstract] [Full Text] [Related]

  • 2. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH, Kwon MJ, Choi EJ, Zheng YF, Yoon KD, Liu KH, Bae SK.
    Chem Biol Interact; 2013 Sep 05; 205(1):11-9. PubMed ID: 23777987
    [Abstract] [Full Text] [Related]

  • 3. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
    Chang Y, Fang WB, Lin SN, Moody DE.
    Basic Clin Pharmacol Toxicol; 2011 Jan 05; 108(1):55-62. PubMed ID: 20825389
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
    He M, Jiang J, Qiu F, Liu S, Peng P, Gao C, Miao P.
    Food Chem Toxicol; 2013 Jul 05; 57():262-5. PubMed ID: 23583485
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activities.
    Satoh T, Fujisawa H, Nakamura A, Takahashi N, Watanabe K.
    J Pharm Pharm Sci; 2016 Jul 05; 19(2):188-97. PubMed ID: 27518169
    [Abstract] [Full Text] [Related]

  • 6. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H, White RB, Stevens JC.
    Drug Metab Dispos; 1996 Sep 05; 24(9):948-54. PubMed ID: 8886603
    [Abstract] [Full Text] [Related]

  • 7. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X, Wang JS, Neuvonen PJ, Backman JT.
    Eur J Clin Pharmacol; 2002 Jan 05; 57(11):799-804. PubMed ID: 11868802
    [Abstract] [Full Text] [Related]

  • 8. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
    Yamazaki H, Shimada T.
    Xenobiotica; 1999 Mar 05; 29(3):231-41. PubMed ID: 10219964
    [Abstract] [Full Text] [Related]

  • 9. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY, Li W, Traeger SC, Wang B, Cui D, Zhang H, Wen B, Rodrigues AD.
    Drug Metab Dispos; 2008 Dec 05; 36(12):2513-22. PubMed ID: 18787056
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
    Liu S, Wang Z, Chan E, Zhao Y, Kang J, Zhang X, Tian X.
    Chem Biol Interact; 2022 Jan 25; 352():109775. PubMed ID: 34910929
    [Abstract] [Full Text] [Related]

  • 11. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT, Chang YW, Lan SJ, Chen CT, Hsu JT, Yeh TK.
    Life Sci; 2006 Nov 25; 79(26):2432-40. PubMed ID: 16978661
    [Abstract] [Full Text] [Related]

  • 12. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
    Ramírez J, Innocenti F, Schuetz EG, Flockhart DA, Relling MV, Santucci R, Ratain MJ.
    Drug Metab Dispos; 2004 Sep 25; 32(9):930-6. PubMed ID: 15319333
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS, Abd Majid FA, Abd Wahid ME, Zainudin AN, Zainol SN, Ismail HF, Wong TS, Tiwari NK, Giri S, Bhargava V.
    Drug Metab Lett; 2018 Sep 25; 12(1):62-67. PubMed ID: 29542427
    [Abstract] [Full Text] [Related]

  • 14. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.
    Hamaoka N, Oda Y, Hase I, Asada A.
    Br J Anaesth; 2001 Apr 25; 86(4):540-4. PubMed ID: 11573629
    [Abstract] [Full Text] [Related]

  • 15. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S, Fujimaki Y, Yokoyama H, Okazaki O, Sudo K.
    Drug Metab Dispos; 2005 Nov 25; 33(11):1628-36. PubMed ID: 16049129
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH, Kwon SS, Jeong HU, Lee HS.
    Int J Mol Sci; 2017 May 01; 18(5):. PubMed ID: 28468305
    [Abstract] [Full Text] [Related]

  • 17. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A in vitro.
    Paludetto MN, Kurkela M, Kahma H, Backman JT, Niemi M, Filppula AM.
    Drug Metab Dispos; 2023 Mar 01; 51(3):293-305. PubMed ID: 36446607
    [Abstract] [Full Text] [Related]

  • 18. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
    Muto S, Fujita K, Yamazaki Y, Kamataki T.
    Mutat Res; 2001 Aug 08; 479(1-2):197-206. PubMed ID: 11470492
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB, Surry D, Price RJ, Lake BG, Evans DC.
    Xenobiotica; 2000 Oct 08; 30(10):955-69. PubMed ID: 11315104
    [Abstract] [Full Text] [Related]

  • 20. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivity.
    Kahma H, Aurinsalo L, Neuvonen M, Katajamäki J, Paludetto MN, Viinamäki J, Launiainen T, Filppula AM, Tornio A, Niemi M, Backman JT.
    Eur J Pharm Sci; 2021 Jul 01; 162():105810. PubMed ID: 33753217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.